Healthcare provider profile · identity verified

Daniel Brueggemann, M.D.

Family Practice · MISSION HILLS, CA · NPI 1518104173

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	552	190
Amlodipine Besylate	Amlodipine Besylate	246	80
Metformin Hcl	Metformin Hcl	215	75
Losartan Potassium	Losartan Potassium	205	70
Lisinopril	Lisinopril	191	59
Gabapentin	Gabapentin	169	80
Levothyroxine Sodium	Levothyroxine Sodium	148	43
Hydrochlorothiazide	Hydrochlorothiazide	147	49
Diclofenac Sodium	Diclofenac Sodium	142	47
Ibuprofen	Ibuprofen	131	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	119	27
Tamsulosin Hcl	Tamsulosin Hcl	103	43
Albuterol Sulfate Hfa	Albuterol Sulfate	98	34
Omeprazole	Omeprazole	94	39
Pantoprazole Sodium	Pantoprazole Sodium	92	35
Metoprolol Tartrate	Metoprolol Tartrate	90	28
Benazepril Hcl	Benazepril Hcl	85	29
Metoprolol Succinate	Metoprolol Succinate	85	27
Trazodone Hcl	Trazodone Hcl	81	27
Famotidine	Famotidine	80	29
Eliquis	Apixaban	76	24
Ozempic	Semaglutide	76	21
Rosuvastatin Calcium	Rosuvastatin Calcium	76	26
Furosemide	Furosemide	75	33
Glipizide	Glipizide	75	26
Finasteride	Finasteride	74	23
Alprazolam	Alprazolam	73	21
Fluticasone Propionate	Fluticasone Propionate	71	34
Atenolol	Atenolol	68	22
Tramadol Hcl	Tramadol Hcl	62	27
Prednisone	Prednisone	60	37
Montelukast Sodium	Montelukast Sodium	57	25
Pravastatin Sodium	Pravastatin Sodium	53	16
Tizanidine Hcl	Tizanidine Hcl	53	suppressed
Sertraline Hcl	Sertraline Hcl	52	17
Simvastatin	Simvastatin	52	16
Carvedilol	Carvedilol	49	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	19
Triamcinolone Acetonide	Triamcinolone Acetonide	49	34
Azelastine Hcl	Azelastine Hcl	48	20
Clopidogrel	Clopidogrel Bisulfate	44	19
Glipizide Er	Glipizide	44	15
Naproxen	Naproxen	44	21
Azithromycin	Azithromycin	42	34
Allopurinol	Allopurinol	41	15
Lorazepam	Lorazepam	41	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	40	29
Acetaminophen-Codeine	Acetaminophen With Codeine	38	22
Metformin Hcl Er	Metformin Hcl	38	13
Alendronate Sodium	Alendronate Sodium	37	15
Meclizine Hcl	Meclizine Hcl	37	17
Trulicity	Dulaglutide	37	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	11
Potassium Chloride	Potassium Chloride	36	14
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Hydrocortisone	Hydrocortisone	33	15
Pioglitazone Hcl	Pioglitazone Hcl	33	suppressed
Temazepam	Temazepam	33	suppressed
Meloxicam	Meloxicam	32	15
Propranolol Hcl	Propranolol Hcl	32	12
Bumetanide	Bumetanide	30	11
Oxybutynin Chloride Er	Oxybutynin Chloride	29	16
Lactulose	Lactulose	28	18
Cephalexin	Cephalexin	27	25
Januvia	Sitagliptin Phosphate	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	11
Donepezil Hcl	Donepezil Hcl	25	suppressed
Lovastatin	Lovastatin	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	13
Terazosin Hcl	Terazosin Hcl	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	20
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	20
Clobetasol Propionate	Clobetasol Propionate	22	12
Warfarin Sodium	Warfarin Sodium	22	suppressed
Cefuroxime	Cefuroxime Axetil	21	18
Clonazepam	Clonazepam	21	suppressed
Nystatin	Nystatin	21	suppressed
Amoxicillin	Amoxicillin	20	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Ondansetron Odt	Ondansetron	20	15
Spironolactone	Spironolactone	20	suppressed
Sucralfate	Sucralfate	20	13
Colchicine	Colchicine	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Sildenafil Citrate	Sildenafil Citrate	19	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	18	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Baclofen	Baclofen	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Mupirocin	Mupirocin	16	11
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Fluconazole	Fluconazole	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Santyl	Collagenase Clostridium Hist.	15	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Triazolam	Triazolam	13	suppressed
Diazepam	Diazepam	12	suppressed
Megestrol Acetate	Megestrol Acetate	12	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	12	12
Ofloxacin	Ofloxacin	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Constulose	Lactulose	11	suppressed
Digoxin	Digoxin	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Ramipril	Ramipril	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error